This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Teggi, A Articles by De Rosa, F Search for Related Content PubMed PubMed Citation Articles by Teggi, A Articles by De Rosa, F

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1993 August; 37(8): 1679-1684

Therapy of human hydatid disease with mebendazole and albendazole.

A Teggi, M G Lastilla and F De Rosa

Second Chair of Infectious Diseases, Università degli Studi di Roma La Sapienza, Italy.

ABSTRACT

We report our experience in the treatment with benzoimidazole carbamates (mebendazole and albendazole) of 337 patients affected by hydatid cysts with different localizations. The treated cysts showed degenerative modifications in 50.6% of the cases after mebendazole treatment and in about 80% after albendazole treatment. Relapses after therapy were observed in 30% of the cases; about 95% of the recurring cysts showed good susceptibility to a further cycle of therapy with benzoimidazole carbamates. Side effects observed with either drug were not severe and always reversible, consisting mainly of abdominal pains and increased levels of transaminases in serum. Among the factors that may influence the therapeutic results are the drug employed, the age of the cysts, the age of the patient, and the localization of the cysts and their morphological characteristics. Moreover, it can be hypothesized that each hydatid cyst has an intrinsic sensitivity to benzoimidazole carbamates.

---

Antimicrob Agents Chemother. 1993 August; 37(8): 1679-1684

This article has been cited by other articles:

• Capan, M., Keltner, S., Thalhammer, F., Winkler, S., Jager, W., Zeitlinger, M., Ramharter, M. (2009). Intra-Cystic Drug Concentration of Albendazole Sulphoxide in Patients with Echinococcus granulosus Cysts. Am J Trop Med Hyg 81: 712-713 [Abstract] [Full Text]  
• Gavidia, C. M., Gonzalez, A. E., Lopera, L., Jayashi, C., Angelats, R., Barron, E. A., Ninaquispe, B., Villarreal, L., Garcia, H. H., Verastegui, M. R., Gilman, R. H. (2009). Evaluation of Nitazoxanide and Oxfendazole Efficacy against Cystic Echinococcosis in Naturally Infected Sheep. Am J Trop Med Hyg 80: 367-372 [Abstract] [Full Text]  
• Junghanss, T., da Silva, A. M., Horton, J., Chiodini, P. L., Brunetti, E. (2008). Clinical Management of Cystic Echinococcosis: State of the Art, Problems, and Perspectives. Am J Trop Med Hyg 79: 301-311 [Abstract] [Full Text]  
• Safioleas, M. C., Misiakos, E. P., Kouvaraki, M., Stamatakos, M. K., Manti, C. P., Felekouras, E. S. (2006). Hydatid Disease of the Liver: A Continuing Surgical Problem. Arch Surg 141: 1101-1108 [Abstract] [Full Text]  
• Lucey, B. C., Kuligowska, E. (2006). Radiologic Management of Cysts in the Abdomen and Pelvis. Am. J. Roentgenol. 186: 562-573 [Abstract] [Full Text]  
• Gharaibeh, K I A (2001). Laparoscopic excision of splenic hydatid cyst. Postgrad. Med. J. 77: 195-196 [Abstract] [Full Text]  
• Jura, H., Bader, A., Frosch, M. (1998). In Vitro Activities of Benzimidazoles against Echinococcus multilocularis Metacestodes. Antimicrob. Agents Chemother. 42: 1052-1056 [Abstract] [Full Text]  
• Khuroo, M. S., Wani, N. A., Javid, G., Khan, B. A., Yattoo, G. N., Shah, A. H., Jeelani, S. G. (1997). Percutaneous Drainage Compared with Surgery for Hepatic Hydatid Cysts. NEJM 337: 881-887 [Abstract] [Full Text]